drugset / Trial / NCT02227888
PK Study of N91115 in Cystic Fibrosis Patients
NaSingle-groupOpen-labelTreatment
Summary
This Phase 1 study in F508del-CFTR homozygous CF patients is being conducted to assess the pharmacokinetics and absorption dynamics of N91115 compared with healthy subjects in order to identify an initial starting dose for Phase 2 trials.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cavosonstat | Small molecule | 50 mg | Oral |